secondary adrenocortical insufficiency

sec·on·dar·y a·dre·no·cor·ti·cal in·suf·fi·cien·cy

adrenocortical insufficiency caused by failure of ACTH secretion resulting from anterior pituitary disease or inhibition of ACTH production resulting from exogenous steroid therapy.

sec·on·dar·y a·dre·no·cor·ti·cal in·suf·fi·cien·cy

(sek'ŏn-dar-ē ă-drē'nō-kōr'ti-kăl in'sŭ-fish'ĕn-sē)
Adrenocortical insufficiency caused by failure of adrenocorticotropic hormone secretion resulting from anterior pituitary disease or inhibition of adrenocorticotropic hormone production resulting from exogenous steroid therapy.
References in periodicals archive ?
today announced that it has acquired a royalty interest in the United States sales of Cortrosyn(R), an injectible diagnostic drug used for the detection of primary or secondary adrenocortical insufficiency.
Cortrosyn is a diagnostic agent used for the detection of primary or secondary adrenocortical insufficiency.
Florinef, which is marketed by Monarch Pharmaceuticals, a division of King Pharmaceuticals (NYSE:KG), as partial replacement for primary and secondary adrenocortical insufficiency in Addison's disease, had sales of approximately $27 million in the U.